1213 related articles for article (PubMed ID: 24522112)
1. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
[TBL] [Abstract][Full Text] [Related]
2. Ghrelin protects against cobalt chloride-induced hypoxic injury in cardiac H9c2 cells by inhibiting oxidative stress and inducing autophagy.
Tong XX; Wu D; Wang X; Chen HL; Chen JX; Wang XX; Wang XL; Gan L; Guo ZY; Shi GX; Zhang YZ; Jiang W
Peptides; 2012 Dec; 38(2):217-27. PubMed ID: 23000094
[TBL] [Abstract][Full Text] [Related]
3. Salidroside improves doxorubicin-induced cardiac dysfunction by suppression of excessive oxidative stress and cardiomyocyte apoptosis.
Wang XL; Wang X; Xiong LL; Zhu Y; Chen HL; Chen JX; Wang XX; Li RL; Guo ZY; Li P; Jiang W
J Cardiovasc Pharmacol; 2013 Dec; 62(6):512-23. PubMed ID: 24072175
[TBL] [Abstract][Full Text] [Related]
4. Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C.
Ludke A; Akolkar G; Ayyappan P; Sharma AK; Singal PK
PLoS One; 2017; 12(7):e0179452. PubMed ID: 28678856
[TBL] [Abstract][Full Text] [Related]
5. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.
Gratia S; Kay L; Potenza L; Seffouh A; Novel-Chaté V; Schnebelen C; Sestili P; Schlattner U; Tokarska-Schlattner M
Cardiovasc Res; 2012 Aug; 95(3):290-9. PubMed ID: 22461523
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells.
Guo R; Lin J; Xu W; Shen N; Mo L; Zhang C; Feng J
Int J Mol Med; 2013 Mar; 31(3):644-50. PubMed ID: 23338126
[TBL] [Abstract][Full Text] [Related]
8. Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling.
Zhang J; Wang M; Ding W; Zhao M; Ye J; Xu Y; Wang Z; Ye D; Li D; Liu J; Wan J
Biochem Pharmacol; 2020 Oct; 180():114188. PubMed ID: 32750329
[TBL] [Abstract][Full Text] [Related]
9. Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy.
Sun A; Cheng Y; Zhang Y; Zhang Q; Wang S; Tian S; Zou Y; Hu K; Ren J; Ge J
J Mol Cell Cardiol; 2014 Jun; 71():92-104. PubMed ID: 24434637
[TBL] [Abstract][Full Text] [Related]
10. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy.
Zhang QL; Yang JJ; Zhang HS
Biomed Pharmacother; 2019 Jan; 109():71-83. PubMed ID: 30396094
[TBL] [Abstract][Full Text] [Related]
11. Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells.
Guo RM; Xu WM; Lin JC; Mo LQ; Hua XX; Chen PX; Wu K; Zheng DD; Feng JQ
Mol Med Rep; 2013 Aug; 8(2):603-8. PubMed ID: 23807148
[TBL] [Abstract][Full Text] [Related]
12. Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes.
Yamamoto Y; Hoshino Y; Ito T; Nariai T; Mohri T; Obana M; Hayata N; Uozumi Y; Maeda M; Fujio Y; Azuma J
Cardiovasc Res; 2008 Jul; 79(1):89-96. PubMed ID: 18346979
[TBL] [Abstract][Full Text] [Related]
13. Activation of AMP-activated protein kinase contributes to doxorubicin-induced cell death and apoptosis in cultured myocardial H9c2 cells.
Chen MB; Wu XY; Gu JH; Guo QT; Shen WX; Lu PH
Cell Biochem Biophys; 2011 Jul; 60(3):311-22. PubMed ID: 21274754
[TBL] [Abstract][Full Text] [Related]
14. Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity.
Lv X; Zhu Y; Deng Y; Zhang S; Zhang Q; Zhao B; Li G
Toxicology; 2020 Aug; 441():152508. PubMed ID: 32525084
[TBL] [Abstract][Full Text] [Related]
15. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
[TBL] [Abstract][Full Text] [Related]
16. Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity.
Lee KH; Cho H; Lee S; Woo JS; Cho BH; Kang JH; Jeong YM; Cheng XW; Kim W
Int J Cardiol; 2017 Apr; 232():40-47. PubMed ID: 28159361
[TBL] [Abstract][Full Text] [Related]
17. Exogenous hydrogen sulfide protects H9c2 cardiac cells against high glucose-induced injury by inhibiting the activities of the p38 MAPK and ERK1/2 pathways.
Xu W; Wu W; Chen J; Guo R; Lin J; Liao X; Feng J
Int J Mol Med; 2013 Oct; 32(4):917-25. PubMed ID: 23912965
[TBL] [Abstract][Full Text] [Related]
18. Taurine prevents arsenic-induced cardiac oxidative stress and apoptotic damage: role of NF-kappa B, p38 and JNK MAPK pathway.
Ghosh J; Das J; Manna P; Sil PC
Toxicol Appl Pharmacol; 2009 Oct; 240(1):73-87. PubMed ID: 19616567
[TBL] [Abstract][Full Text] [Related]
19. Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NFκB pathway in H9c2 cardiac cells.
Guo R; Wu K; Chen J; Mo L; Hua X; Zheng D; Chen P; Chen G; Xu W; Feng J
Cell Physiol Biochem; 2013; 32(6):1668-80. PubMed ID: 24356372
[TBL] [Abstract][Full Text] [Related]
20. Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice.
Thandavarayan RA; Watanabe K; Sari FR; Ma M; Lakshmanan AP; Giridharan VV; Gurusamy N; Nishida H; Konishi T; Zhang S; Muslin AJ; Kodama M; Aizawa Y
Free Radic Biol Med; 2010 Nov; 49(9):1422-31. PubMed ID: 20705132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
